The sales process for the remaining bulk of financially troubled UK care home operator Four Seasons' assets has not been quick. HBI speaks to a market expert and to the group's property advisors to ask why the sale is taking so long.
The UK Competition and Markets Authority (CMA) has said the proposed merger between dental groups Portman Dental Care and Dentex Healthcare raises competition issues, and will be investigated further unless suitable undertakings are received.
IHH-owned Turkish hospital group Acibadem has opened a contact centre in the Harley Street medical area in the UK and has an eye on market opportunities. HBI speaks to an operator and an advisor to find out more.
The sale process for pan-European radiology group RAD-x may have stalled, with no statements on progress from any of the parties involved. A well-placed German imaging operator tells HBI that the sale will no longer go ahead, while the group itself is giving nothing away.
Global investment manager AXA IM Alts (the alternative investment arm of AXA IM) has joined forces with Spanish real estate investor Grupo Lar to invest in Spanish health care real estate assets, marking its launch into the Spanish health care market.
HBI chats with mydentist CFO Richard Storah about the UK-based dental group’s history, its plans for 2023 and beyond, and how he sees the post-pandemic market.
The EU has given the green light to a joint venture between Centric Health, Ireland’s only major private primary care chain, and Irish Life Health, one of Ireland’s four private health insurers. The joint venture will provide a new digi-physical primary care service to Irish Life Health customers.
CVS, the largest pharmacy chain in the US, is reportedly considering buying listed primary care chain Oak Street Health for $10bn, as part of its strategy to gain control over the entire patient pathway. Oak Street’s shares rose 33% after the news broke on Monday, January 9, giving the company a market cap of over $7bn at the time of writing.
Multiple sources tell HBI Spanish for-profit hospital group Grupo Recoletas is up for sale, and rival HM Hospitales could follow if it hasn't already. Recoletas outright denies there is any process.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.